Acro Biomedical Co., Ltd. (6748) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Acro Biomedical Co., Ltd. (6748:TWSE), powered by AI.

Current Price
$134.50
Sector
Healthcare
What is the Acro Biomedical Co., Ltd. stock price forecast?

Acro Biomedical Co., Ltd. is currently trading at $134.50. View real-time AI analysis on Alpha Lenz.

What is Acro Biomedical Co., Ltd. insider trading activity?

View the latest insider trading data for Acro Biomedical Co., Ltd. on Alpha Lenz.

What is Acro Biomedical Co., Ltd.'s P/E ratio?

View Acro Biomedical Co., Ltd.'s valuation metrics on Alpha Lenz.

Acro Biomedical Co., Ltd.

TWSE · 6748
NT$134.50+15.00(+12.55%)
Ask about Acro Biomedical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Acro Biomedical Co., Ltd.'s ROE is -9.6%. Explore profitability and growth together.

Ask for details

Company Overview

Acro Biomedical Co., Ltd. is a healthcare company specializing in the development and manufacturing of medical-grade regenerative biomaterials. Founded in 2014 and based in Kaohsiung, Taiwan, the company focuses on creating advanced biomaterial medical devices for applications in human tissue engineering and regenerative medicine. Its products serve critical roles in a variety of fields, including wound care, orthopedics, dentistry, cardiovascular surgery, ophthalmology, and cosmetic micro plastic surgery. Leveraging collaborations with prominent scientific institutes and medical centers in Taiwan, Acro Biomedical integrates multidisciplinary research and innovation to address unmet medical needs, particularly in tissue repair and regeneration. The company has received multiple regulatory approvals and patents for its biomaterial technologies, targeting both domestic and international markets. By emphasizing high standards in biomaterial purification and device manufacturing, Acro Biomedical Co., Ltd. supports the ongoing advancement of medical treatments and specialty care across the healthcare sector.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$38.26MRevenue
0.00Shares Out
0Employees

Margins

48.43%Gross
-174.01%EBITDA
-242.80%Operating
-216.06%Pre-Tax
-216.06%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

11.45%Rev 3Yr
16.23%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-9.25%ROA
-9.55%ROE
-9.22%ROIC

Financial Health

NT$770.67MCash & Cash Equivalents
NT$-742.56MNet Debt
2.55%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Acro Biomedical Co., Ltd. (ticker: 6748) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 134.5 with a P/E ratio of -x and P/B of -x.

ROE is -9.55% and operating margin is -242.80%. Annual revenue is $38M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Acro Biomedical Co., Ltd. (6748) Stock Forecast 2026 $134.50 — Price, Financials & Analyst Targets | Alpha Lenz